1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
Magnesium supplementation in pregnancy. A double-blind study
Article first published online: 19 AUG 2005
DOI: 10.1111/j.1471-0528.1988.tb06839.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 95, Issue 2, pages 120–125, February 1988
Additional Information
How to Cite
SPÄTLING, L. and SPÄTLING, G. (1988), Magnesium supplementation in pregnancy. A double-blind study. BJOG: An International Journal of Obstetrics & Gynaecology, 95: 120–125. doi: 10.1111/j.1471-0528.1988.tb06839.x
Publication History
- Issue published online: 19 AUG 2005
- Article first published online: 19 AUG 2005
- Received 6 January 1987 Accepted 15 June 1987
- Abstract
- References
- Cited By
Summary. The effect of magnesium supplementation in pregnancy was studied in 568 women who were treated with 15 mmol magnesiumaspartate-hydrochloride per day or aspartic acid as placebo given orally during pregnancy from 
16 weeks. Allocation to the two groups was performed according to the women's birthdates. Magnesium supplementation during pregnancy was associated with significantly fewer maternal hospitalizations, a reduction in preterm delivery, and less frequent referral of the newborn to the neonatal intensive care unit. The results suggest that magnesium supplementation during pregnancy has a significant influence on fetal and maternal morbidity both before and after delivery.